참고문헌
- Nagy, G., Koncz, A. and Perl, A. : T- and B-cell abnormalities in systemic lupus erythematosus. Crit. Rev. Immunol. 25, 123 (2005). https://doi.org/10.1615/CritRevImmunol.v25.i2.30
- Takeuchi, T., Tsuzaka, K., Abe, T., Yoshimoto, K., Shiraishi, K., Kameda, H. and Amano, K. : T cell abnormalities in systemic lupus erythematosus. Autoimmunity 38, 339 (2005). https://doi.org/10.1080/08916930500123983
- Chae, B. S. and Shin, T. Y. : Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice. Arch. Pharm. Res. 30, 191 (2007). https://doi.org/10.1007/BF02977694
- Xu, L., Zhang, L., Yi, Y., Kang, H. K. and Datta, S. K. : Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat. Med. 10, 411 (2004). https://doi.org/10.1038/nm1005
- Takeno, M., Nagafuchi, H., Kaneko, S., Wakisaka, S., Oneda, K., Takeba, Y., Yamashita, N., Suzuki, N., Kaneoka, H. and Sakane, T. : Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J. Immunol. 158, 3529 (1997).
- Reininger, L., Santiago, M. L., Takahashi, S., Fossati, L. and Izui, S. : T helper cell subsets in the pathogenesis of systemic lupus erythematosus. Ann. Med. Interne. (Paris) 147, 467 (1996).
- Ishikawa, S., Akakura, S., Abe, M., Terashima, K., Chijiiwa, K., Nishimura, H., Hirose, S. and Shirai, T. : A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance. J. Immunol. 161, 1267 (1998).
-
Portales-Perez, D., Gonzalez-Amaro, R., Abud-Mendoza, C. and Sanchez-Armass, S. : Abnormalities in CD69 expression, cytosolic pH and
$Ca^{2+}$ during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus 6, 48 (1997). https://doi.org/10.1177/096120339700600107 - Crispin, J. C., Martinez, A., de Pablo, P., Velasquillo, C. and Alcocer-Varela, J. : Participation of the CD69 antigen in the Tcell activation process of patients with systemic lupus erythematosus. Scand. J. Immunol. 48, 196 (1998). https://doi.org/10.1046/j.1365-3083.1998.00366.x
- Jordan, N. and D'Cruz, D. : Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications. Ther. Adv. Musculoskelet Dis. 7, 234 (2015). https://doi.org/10.1177/1759720X15601805
- Steiman, A. J., Gladman, D. D., Ibanez, D., Noamani, B., Landolt-Marticorena, C., Urowitz, M. B. and Wither, J. E. : Lack of Interferon and proinflammatory cyto/chemokines in serologically active clinically quiescent systemic lupus erythematosus. J. Rheumatol. 42, 2318 (2015). https://doi.org/10.3899/jrheum.150040
- Aringer, M. and Smolen, J. S. : SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res. Ther. 5, 172 (2003).
- Chun, H. Y., Chung, J. W., Kim, H. A., Yun, J. M., Jeon, J. Y., Ye, Y. M., Kim, S. H., Park, H. S. and Suh, C. H. : Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol. 27, 461 (2007). https://doi.org/10.1007/s10875-007-9104-0
- Dean, G. S., Tirrell-Price, J., Crawley, E. and Isenberg, D. A. : Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis. 59, 243 (2000). https://doi.org/10.1136/ard.59.4.243
- Haas, C., Ryffel, B. and Le Hir, M. : IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J. Immunol. 160, 3713 (1998).
- Liang, B., Gardner, D. B., Griswold, D. E., Bugelski, P. J. and Song, X. Y. : Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 119, 296 (2006). https://doi.org/10.1111/j.1365-2567.2006.02433.x
- Richards, H. B., Satoh, M., Shaw, M., Libert, C., Poli, V. and Reeves, W. H. : Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188, 985 (1998). https://doi.org/10.1084/jem.188.5.985
- Beebe, A. M., Cuab, D. J. and de Waal Malefyt, R. : The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine & Growth Factor Reviews 13, 403 (2002). https://doi.org/10.1016/S1359-6101(02)00025-4
-
Tsai, C. Y., Wu, T. H., Tsai, S. T., Chen, K. H., Thajeb, P., Lin, W. M., Yu, H. S. and Yu, C.L. : Cerebrospinal fluid interleukin- 6, prostaglandin
$E_2$ and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections. Scand. J. Rheumatol. 23, 57 (1994). https://doi.org/10.3109/03009749409103028 -
Chae, B. S., Shin, T. Y., Kim, D. K., Eun, J. S., Leem, J. Y. and Yang, J. H. : Prostaglandin
$E_2$ -mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. Arch. Pharm. Res. 31, 503 (2008). https://doi.org/10.1007/s12272-001-1185-6 - Li-Weber, M. : New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 35, 57 (2009). https://doi.org/10.1016/j.ctrv.2008.09.005
- Gao, Z., Huang, K., Yang, X. and Xu, H. : Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim. Biophys. Acta. 1472, 643 (1999). https://doi.org/10.1016/S0304-4165(99)00152-X
- Wang, H. and Liu, D. : Baicalin inhibits high-mobility group box 1 release and improves survival in experimental sepsis. Shock 41, 324 (2014). https://doi.org/10.1097/SHK.0000000000000122
- Zhu, J., Wang, J., Sheng, Y., Zou, Y., Bo, L., Wang, F., Lou, J., Fan, X., Bao, R., Wu, Y., Chen, F., Deng, X. and Li, J. : Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 7, e35523 (2012). https://doi.org/10.1371/journal.pone.0035523
- Liu, L. L., Gong, L. K., Wang, H., Xiao, Y., Wu, X. F., Zhang, Y. H., Xue, X., Qi, X. M. and Ren, J. : Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock. Biochem. Pharmacol. 75, 914 (2008). https://doi.org/10.1016/j.bcp.2007.10.009
- Xu, J., Huang, R., Yang, Y. J., Jin, S. J. and Zhang, J. F. : Effects of baicalin on apoptosis in rats with autoimmune encephalomyelitis. Zhongguo Dang Dai Er Ke Za Zhi 13, 665 (2011).
- Yang, J., Yang, X. and Li, M. : Baicalin, a natural compound, promotes regulatory T cell differentiation. BMC Complement Altern. Med. 12, 64 (2012).
- Shacter, E., Arzadon, G. K. and Williams, J. : Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood 80, 194 (1992).
- Chae, B. S. : Baicalin amelirates dysimmunoregulation in pristane-induced lupus mice: production of IL-6 and PGE2 and activation of T cells. Nat. Prod. Sci. 17, 354 (2011).
- Svenungsson, E., Fei, G. Z., Jensen-Urstad, K., de Faire, U., Hamsten, A. and Frostegard, J. : TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 12, 454 (2003). https://doi.org/10.1191/0961203303lu412oa
-
Qu, H., Bian, W. and Xu, Y. : A novel NF-
${\kappa}B$ inhibitor, DHMEQ, ameliorates pristane-induced lupus in mice. Exp. Ther. Med. 8, 100 (2014). https://doi.org/10.3892/etm.2014.1718 - Miyagaki, T., Fujimoto, M. and Sato, S. : Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research. Int. Immunol. 27, 495 (2015). https://doi.org/10.1093/intimm/dxv026
- Sim, J. H., Kim, H. R., Chang, S. H., Kim, I. J., Lipsky, P. E. and Lee, J. : Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus. Arthritis Res. Ther. 17, 190 (2015). https://doi.org/10.1186/s13075-015-0687-1
-
Kalinski, P. : Regulation of immune responses by prostaglandin
$E_2$ . J. Immunol. 188, 21 (2012). https://doi.org/10.4049/jimmunol.1101029 -
Hinson., R. M., Williams, J. A. and Shacter, E. : Elevated interleukin 6 is induced by prostaglandin
$E_2$ in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. U S A 93, 4885 (1996). https://doi.org/10.1073/pnas.93.10.4885 - Mene, P., Pecci, G., Cinotti, G. A., Pugliese, G., Pricci, F. and Pugliese, F. : Eicosanoid synthesis in peripheral blood monocytes: a of disease activity in lupus nephritis. Am. J. Kidney Dis. 32, 778 (1998). https://doi.org/10.1016/S0272-6386(98)70133-7
- Dillon, A. M., Stein, H. B. and English, R. A. : Splenic atrophy in systemic lupus erythematosus. Ann. Intern. Med. 96, 40 (1982). https://doi.org/10.7326/0003-4819-96-1-40
- Piliero, P. and Furie, R. : Functional asplenia in systemic lupus erythematosus. Semin. Arthritis Rheum. 20, 185 (1990). https://doi.org/10.1016/0049-0172(90)90059-O
- Yang, X., Sun, B., Wang, H., Yin, C., Wang, X. and Ji, X. : Increased serum IL-10 in lupus patients promotes apoptosis of T cell subsets via the caspase 8 pathway initiated by Fas signaling. J. Biomed. Res. 29, 232 (2015).
- Panarese, A., D'Andrea, V., Pironi, D. and Filippini, A. : Thymectomy and systemic lupus erythematosus (SLE). Ann. Ital. Chir. 85, 617 (2014).
- Gottschalk, T. A., Tsantikos, E. and Hibbs, M. L. : Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front. Immunol. 6, 550 (2015).
- Mathian, A., Hie, M., Cohen-Aubart, F. and Amoura, Z. : Targeting interferons in systemic lupus erythematosus: current and future prospects. Drugs 75, 835 (2015). https://doi.org/10.1007/s40265-015-0394-x
- Balomenos, D., Rumold, R. and Theofilopoulos, A. N. : Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101, 364 (1998). https://doi.org/10.1172/JCI750
- Harigai, M., Kawamoto, M., Hara, M., Kubota, T., Kamatani, N. and Miyasaka, N. : Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J. Immunol. 181, 2211 (2008). https://doi.org/10.4049/jimmunol.181.3.2211